
11 - 50 funcionários
Fundada em 2015
💊 Farmacêutico
🧬 Biotecnologia
Pharmaceuticals • Biotechnology
A Achieve Life Sciences é uma empresa farmacêutica especializada em fase avançada, focada no desenvolvimento de citisiniclina como tratamento para dependência de nicotina (cessação do tabagismo e vaping). A empresa está avançando com a citisiniclina através dos estudos ORCA Fase 2 e Fase 3 e submeteu um NDA; seu programa clínico visa os receptores nicotínicos para reduzir a abstinência e a satisfação do tabagismo, com o objetivo de oferecer uma nova opção de tratamento aprovada pela FDA para dependência de tabaco e nicotina.
🕒 Julho 27
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $260.000 - $320.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

11 - 50 funcionários
Fundada em 2015
💊 Farmacêutico
🧬 Biotecnologia
Pharmaceuticals • Biotechnology
A Achieve Life Sciences é uma empresa farmacêutica especializada em fase avançada, focada no desenvolvimento de citisiniclina como tratamento para dependência de nicotina (cessação do tabagismo e vaping). A empresa está avançando com a citisiniclina através dos estudos ORCA Fase 2 e Fase 3 e submeteu um NDA; seu programa clínico visa os receptores nicotínicos para reduzir a abstinência e a satisfação do tabagismo, com o objetivo de oferecer uma nova opção de tratamento aprovada pela FDA para dependência de tabaco e nicotina.
• Developing and leading Achieve Life Sciences’ patient advocacy strategy for cytisinicline, building trusted relationships with patient advocacy organizations, public health coalitions, and community leaders in the nicotine-dependence and tobacco-control space. • Ensuring patient insights and advocacy perspectives are integrated into decision-making across clinical development, market access, and commercialization. • Representing the Company at external advocacy conferences, coalition meetings, and patient-facing events, serving as the primary liaison between Achieve Life Sciences and the patient advocacy community. • Leading the development and execution of Achieve Life Sciences’ public policy strategy, analyzing the federal and state policy environment for tobacco control, nicotine-dependence treatment, and smoking-cessation coverage. • Identifying legislative and regulatory opportunities and risks relevant to cytisinicline, and developing positioning and messaging to advance the Company’s policy priorities. • Ensuring compliance with applicable laws, regulations, and company policies governing lobbying, political activity, and advocacy engagement. • Building and leading the Company’s engagement across lobbyist groups, trade associations, and public health coalitions — including organizations such as the American Lung Association, Truth Initiative, and Campaign for Tobacco-Free Kids — to advance shared policy priorities that support patient access. • Managing relationships with external lobbying firms and consultants, directing lobbying strategy and priorities in alignment with the Company’s commercial and policy objectives. • Cultivating relationships with federal and state policymakers and staff, positioning Achieve Life Sciences as a trusted voice in the nicotine-dependence treatment policy landscape. • Building and leading the patient advocacy and public policy function, recruiting and developing talent to support the Company’s growth.
• Bachelor’s degree in public policy, public health, political science, or a related discipline; an advanced degree (JD, MPH, or MBA) is preferred. • 10+ years of public policy, government affairs, or advocacy experience, including significant experience in the healthcare or biopharmaceutical industry. • Demonstrated success building and leading coalitions across lobbyist groups, trade associations, and patient advocacy organizations, with established relationships in the tobacco-control and public health policy space. • Experience navigating federal and state legislative and regulatory processes relevant to healthcare and tobacco/nicotine policy.
• medical, dental, and vision insurance • a 401(k) retirement plan • participation in the Employee Stock Purchase Plan • company-paid life insurance and short- and long-term disability coverage • paid time off • paid company holidays
Candidatar-se🕒 Julho 27
Vice President of Investor Relations at KCSA driving financial communication strategy and team management in a remote setting. Working with B2B communications in cutting-edge industries.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $140.000 - $175.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
VP leading data implementation and calibration for partners in professional sports organizations. Collaborating closely with various teams to ensure efficient and reliable data outputs.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $165.000 - $185.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
VP of Sales driving Strategic and Enterprise sales teams in a B2B SaaS company focused on AI legal technology for law firms.
🇺🇸 Estados Unidos – Remoto (EUA)
🔥 Investimento no último ano
💰 $103.000.000 Series B - Eve em 2025-09
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
Vice President leading data and analytics products for OptimizeRx. Responsible for product strategy, development, and commercialization in healthcare solutions.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $200.000 - $220.000 / ano
💰 $9.000.000 Post-IPO Equity - OPTIMIZERx em 2018-05
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
VP of Translational Sciences managing the strategy and execution of oncology drug development. Leading translational framework and regulatory readiness for clinical trials at Shasqi.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $300.000 - $325.000 / ano
💰 $1.900.000 Grant em 2022-01
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório